Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

The approval of the first oncolytic virus for the treatment of metastatic melanoma and the compiling evidence that the use of oncolytic viruses can enhance cancer immunotherapies targeted against various immune checkpoint proteins has attracted great interest in the field of cancer virotherapy. We h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Erkko Ylösmäki, Cristina Malorzo, Cristian Capasso, Oona Honkasalo, Manlio Fusciello, Beatriz Martins, Leena Ylösmäki, Antti Louna, Sara Feola, Henrik Paavilainen, Karita Peltonen, Veijo Hukkanen, Tapani Viitala, Vincenzo Cerullo
Format: Artigo
Sprache:Englisch
Veröffentlicht: 2018
Online-Zugang:https://doi.org/10.1016/j.ymthe.2018.06.008
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!